Article Text
Short report
Benign intracranial hypertension associated with the withdrawal of a non-ergot dopamine agonist
Abstract
The cases are reported of two patients who developed benign intracranial hypertension after the withdrawal of the novel non-ergot derived dopamine agonist CV 205 502 (quinagolide).